Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective

Dramatic changes have occurred in our understanding of the etiology of the growth retardation associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD) during the past 50 years. Significant interest has been focused on preventing and/or correcting the growth retardation because of the emergence of the dual therapeutic modalities of dialysis and renal transplantation to prolong the lives of infants, children, and adolescents afflicted with CKD and ESRD. These efforts have resulted in a significant improvement in the height Z-score over the past two decades of children with CKD and ESRD. This has had a salutary impact on the final adult height of such children which should hopefully lead to an enhanced quality of life in the future. This report addresses the progress that has been made in the management of growth retardation in the pediatric population with CKD and ESRD.

[1]  N. Powe,et al.  Growth failure, risk of hospitalization and death for children with end-stage renal disease , 2002, Pediatric Nephrology.

[2]  J. Craig,et al.  Growth hormone for children with chronic renal failure. , 2001, The Cochrane database of systematic reviews.

[3]  B. Tönshoff,et al.  Plasma growth hormone-binding activity is low in uraemic children , 1991, Pediatric Nephrology.

[4]  F. Berthier,et al.  Long-term results of rhGH treatment in children with renal failure: experience of the French Society of Pediatric Nephrology , 2008, Pediatric Nephrology.

[5]  M. Van Dyck,et al.  Conservative treatment for chronic renal failure from birth: a 3-year follow-up study , 1999, Pediatric Nephrology.

[6]  R. Fine,et al.  Factors predictive of sustained growth in children after renal transplantation. The North American Pediatric Renal Transplant Cooperative Study. , 1993, The Journal of pediatrics.

[7]  H. Ginsberg,et al.  Lipoprotein metabolism in chronic renal insufficiency , 2007, Pediatric Nephrology.

[8]  J. Craig,et al.  Growth hormone treatment in children with chronic renal failure: a meta-analysis of randomized controlled trials. , 2001, The Journal of pediatrics.

[9]  O. Salvatierra,et al.  The 1989 report of the North American Pediatric Renal Transplant Cooperative Study , 1990, Pediatric Nephrology.

[10]  E. Bérard,et al.  Effects of growth hormone in short children after renal transplantation , 1998, Pediatric Nephrology.

[11]  G. Reeves,et al.  Growth Hormone Treatment and Pseudotumor Cerebri: Coincidence or Close Relationship? , 2002, Journal of pediatric endocrinology & metabolism : JPEM.

[12]  E. Bérard,et al.  Recombinant human growth hormone treatment of children on hemodialysis , 1998, Pediatric Nephrology.

[13]  F. Kaskel,et al.  Growth hormone axis in chronic kidney disease , 2008, Pediatric Nephrology.

[14]  L. Rees,et al.  Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients , 1998, Archives of disease in childhood.

[15]  P. Betts,et al.  Growth Pattern and Dietary Intake of Children with Chronic Renal Insufficiency , 1974, British medical journal.

[16]  B. Tönshoff,et al.  Effect of growth hormone treatment on the adult height of children with chronic renal failure , 2000 .

[17]  A. Rundle,et al.  Slipped capital femoral epiphysis in children treated with growth hormone. A summary of the National Cooperative Growth Study experience. , 1996, Hormone research.

[18]  C. Lang,et al.  Growth Hormone Treatment in Growth Retarded Children with End Stage Renal Failure: Effect on Free/Dissociable IGF-I Levels , 1997, Journal of pediatric endocrinology & metabolism : JPEM.

[19]  A. Rundle,et al.  Slipped capital femoral epiphysis in children treated with growth hormone. A summary of the National Cooperative Growth Study experience. , 1996, Hormone research.

[20]  B. Tönshoff,et al.  Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia , 1991, Pediatric Nephrology.

[21]  A. Hokken-Koelega,et al.  Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency , 2000, Pediatric Nephrology.

[22]  B. Tönshoff,et al.  Growth hormone/insulin-like growth factor system in children with chronic renal failure , 2005, Pediatric Nephrology.

[23]  K. Schärer,et al.  Alterations in growth hormone secretion and clearance in peripubertal boys with chronic renal failure and after renal transplantation. Cooperative Study Group of Pubertal development in Chronic Renal Failure. , 1994, The Journal of clinical endocrinology and metabolism.

[24]  G. Radetti,et al.  Medium-Term Cardiovascular Effects of High-Dose Growth Hormone Treatment in Growth Hormone-Deficient Children , 1999, Hormone Research in Paediatrics.

[25]  D. Kaufman.  Growth hormone and renal osteodystrophy: a case report , 1998, Pediatric Nephrology.

[26]  E. Avner,et al.  Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study. , 1996, Transplantation.

[27]  R. Fine,et al.  Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone. , 1996, Kidney international.

[28]  D. Stablein,et al.  Contributions of the Transplant Registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) * , 2007, Pediatric transplantation.

[29]  T. Starzl,et al.  OUTCOME AFTER STEROID WITHDRAWAL IN PEDIATRIC RENAL TRANSPLANT PATIENTS RECEIVING TACROLIMUS-BASED IMMUNOSUPPRESSION1 , 1999, Transplantation.

[30]  T. Gasser,et al.  Pubertal Growth in Chronic Renal Failure , 1990, Pediatric Research.

[31]  F. Schaefer,et al.  Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling , 2005, Pediatric Nephrology.

[32]  M. Sarwal,et al.  Steroid‐Free Immunosuppression Since 1999: 129 Pediatric Renal Transplants with Sustained Graft and Patient Benefits , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[33]  P. Niaudet,et al.  LONG-TERM SOCIAL OUTCOME OF CHILDREN AFTER KIDNEY TRANSPLANTATION , 2004, Transplantation.

[34]  G. Rizzoni,et al.  Does growth hormone treatment affect the risk of post-transplant renal cancer? , 2002, Pediatric Nephrology.

[35]  D. Stablein,et al.  Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. , 2002, Kidney international.

[36]  R. Fine,et al.  Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. , 1994, The Journal of pediatrics.

[37]  G. Segre,et al.  Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. , 1994, Kidney international.

[38]  F. Emma,et al.  Growth hormone treatment started in the first year of life in infants with chronic renal failure , 2009, Pediatric Nephrology.

[39]  F. Schaefer,et al.  Psychosocial rehabilitation and satisfaction with life in adults with childhood-onset of end-stage renal disease , 2005, Pediatric Nephrology.

[40]  B. Tönshoff,et al.  Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease , 1996, Pediatric Nephrology.

[41]  C. Roberts,et al.  The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. , 2008, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.